Remove tag digital-agency
article thumbnail

Pharma running online ads on vaccine misinformation sites

World of DTC Marketing

NewsGuard found that 67% of the COVID misinformation sites had Google advertising tags and 30% had tags from The Trade Desk. The programmatic problem shows no signs of improving, and frankly, Pfizer should terminate their relationship with their online agency as this is totally unacceptable. How much is enough? dollars.

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

Technology firm Jolly Good and Teijin Pharma have begun a partnership to develop virtual reality digital therapeutics (VR DTx) for major depressive disorder. The goal of the partnership for approval for the Japanese market from the Pharmaceuticals and Medical Devices Agency (PMDA).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insights from the 18th Annual Canadian Summit on Food Safety in 2024

XTalks

Day 1 Highlights Pamela MacDonald from the Canadian Food Inspection Agency (CFIA) kicked off the conference with insights into future trends in food inspections and the value of collaborative efforts with inspectors. Hatch also discussed the increasing integration of digital technologies like AI in food safety.

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Analysing the world of digitally-native brands highlights three standout ways in which parts of their approach could be brought to the pharmaceutical world.

Branding 130
article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. The key is adapting existing legacy and traditional printed material for the digital environment.”.

article thumbnail

Grand Rounds August 19, 2022: Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change (Gerald Bloomfield, MD, MPH; Michelle Kelsey, MD)

Rethinking Clinical Trials

There is a national priority to increase diversity in clinical trials, from regulatory, funding agencies, industry, and others, so that the participant population reflects the U.S. Duke University School of Medicine. Diversity, Inclusion. Key Points. population at large, which is steadily becoming more diverse. Learn more.

article thumbnail

Grand Rounds June 30, 2023: Decentralized Trials – From Guidance to Reality & What’s Left (Adrian Hernandez, MD, MHS; Pamela Tenaerts, MD, MPH; Craig Lipset, MPH)

Rethinking Clinical Trials

The European Medicines Agency (EMA) released a separate guidance around DCTs in December 2022. Additional considerations are needed for the data management plan, monitoring plan, safety plan, task log, and case report forms in the FDA draft guidance.

Trials 130